News News Select Year All Years 2026 (16) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 488 Results Page 22 of 49« First«...10...2021222324...3040...»Last » August 7, 2019 DBV Technologies Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Peanut for the Treatment of Peanut Allergy August 1, 2019 DBV Technologies Reports First Half 2019 Financial Results July 18, 2019 Amendment to the DBV Technologies Liquidity Contract with NATIXIS ODDO BHF and Half-Year Report June 26, 2019 DBV Technologies Announces Appointment of Pharis Mohideen, M.D., as Chief Medical Officer June 3, 2019 DBV Technologies to Attend Upcoming Investor Conferences June 1, 2019 DBV Technologies to Present Data from Epicutaneous Immunotherapy at EAACI 2019 May 24, 2019 DBV Technologies Announces Results of its 2019 Ordinary and Extraordinary General Meeting and the Appointment of Viviane Monges to the Board of Directors May 14, 2019 DBV Technologies Announces Departure of Deputy CEO David Schilansky May 3, 2019 Ordinary and Extraordinary General Meeting of May 24, 2019 Procedures for Obtaining Preparatory Documents for the General Meeting May 2, 2019 DBV Technologies to Attend Upcoming Investor Conferences Page 22 of 49« First«...10...2021222324...3040...»Last »
